Predictive analytics
In part two of a two-part series, Dr. Bruce Darrow, CMIO and interim CDIO at Mount Sinai Health System, discusses how the health system utilizes AI for predictive care, reading diagnostic images, and streamlining administrative operations.
In part one of a two-part series, Dr. Bruce Darrow, Mount Sinai Health System CMIO and interim CDIO, relays how patients may gain confidence in relying on AI instead of doctors as accuracy of pattern recognition and predictive models improve.
HIMSS24
Dr. Calum Yacoubian, director of NLP healthcare strategy at IQVIA, says AI can support, not replace, clinicians in improving care delivery, and discusses some best practices for its safe and ethical use.
The HIMSS AI in Healthcare Forum is scheduled to take place September 5-6 in Boston. Learn more and register.
HIMSS24
Dr. John Showalter, Linus' chief product officer, discusses the company's cognitive impairment testing and care-delivery offerings for dementia diagnosis and treatment and its acquisition of speech analytics platform Aural Analytics.
Ansys industry director for Healthcare Solutions Thierry Marchal and researcher María Angeles Pérez discuss how combining clinical data and mathematical models can increase precision and expedite treatment plans.
HIMSS24
Dr. Tim O'Connell, cofounder and CEO of Emtelligent, believes healthcare organizations should not rely solely on AI for business processes and must train models on data sets that represent "all of humanity."
The open-source gene editor is freely available to license for commercial use and ethical research.
Atul Singh, general manager of digital health at LG Electronics's Innovation Center LG NOVA, discusses LG's provider-focused technology and how consumer electronics will allow for in-depth health data collection in the future.
Sumit Nagpal, Cherish Health CEO, discusses his new endeavor aimed at health assurance through prevention by using in-home radar technology to track individuals, and the importance of cross-sector collaboration for better patient outcomes.
Also, Seegene will be leveraging Microsoft's AI to advance the development of syndromic quantitative PCR diagnostic tests globally.